Heart Test Laboratories, Inc. (HSCS) |
|
0.4297 -0.003 (-0.79%)
|
10-02 16:00 |
|
Open: |
0.426 |
Pre. Close: |
0.4331 |
|
High:
|
0.4399 |
Low:
|
0.415 |
|
Volume:
|
31,705 |
Market Cap:
|
5(M) |
|
|
|
Technical analysis |
as of: 2023-10-02 4:50:45 PM |
|
Short-term rate:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 0.74 One year: 0.99 |
| Support: |
Support1: 0.3 Support2: 0.24 |
| Resistance: |
Resistance1: 0.64 Resistance2: 0.85 |
| Pivot: |
0.54  |
| Moving Average: |
MA(5): 0.42 MA(20): 0.6
MA(100): 0.84 MA(250): 1.16 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 22.8 %D(3): 22.4 |
| RSI: |
RSI(14): 30.7 |
| 52-week: |
High: 3.95 Low: 0.3 |
| Average Vol(K): |
3-Month: 99 (K) 10-Days: 270 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HSCS ] has closed above bottom band by 34.2%. Bollinger Bands are 156.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.44 - 0.44 |
0.44 - 0.44 |
|
Low:
|
0.41 - 0.41 |
0.41 - 0.41 |
|
Close:
|
0.43 - 0.43 |
0.43 - 0.43 |
|
Company Description |
|
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas. |
Headline News |
Mon, 25 Sep 2023
HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I. - Yahoo Finance
Fri, 22 Sep 2023
Heart Test Laboratories Partners with Maxim Group for Capital Raise - Best Stocks
Fri, 22 Sep 2023
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other ... - Investing.com UK
Thu, 21 Sep 2023
HeartSciences Signs Definitive Agreements with the Icahn School of ... - GlobeNewswire
Thu, 21 Sep 2023
Why Murphy Canyon Acquisition Shares Are Trading Higher By ... - Investing.com UK
Tue, 19 Sep 2023
Scott Schenkel Joins Pinterest Inc Board of Directors - Best Stocks
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
11 (M) |
|
% Held by Insiders
|
8.46e+006 (%) |
|
% Held by Institutions
|
22.8 (%) |
|
Shares Short
|
78 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-5.99e+006 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-308 |
|
Return on Assets (ttm)
|
385.7 |
|
Return on Equity (ttm)
|
-92.1 |
|
Qtrly Rev. Growth
|
1950 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
-0.7 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-5 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
41280 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
